Biomed Israel 2025 – Sponsors and Exhibitors

Cell-Lipo develops a point-of-care platform that converts a patient’s own fat into regenerative therapies for orthopedics and aesthetics, enabling scalable treatments with a recurring revenue model.

Fortrea is a leading global CRO with over 30 years experience, providing comprehensive Phase I-IV trial management, clinical pharmacology, consulting services across 20+ therapeutic areas.

GenScript Biotech Corporation offers highly customizable and tailor-made solutions for your research needs: gene synthesis, protein/mRNA/CRISPR, peptides, oligos, antibodies & catalogue products

H.C. Wainwright is a full-service investment bank based in New York specializing in assisting our clients to navigate the complex equity capital markets environment

JMB Davis Ben-David is a bi-jurisdictional Israel and US IP boutique. We provide strategic patent, trademark, and design protection for global innovations across high-tech and biotech sectors.

LifeSci Partners is a global consulting firm focused exclusively on the life sciences sector. Our platform spans Investor Relations, Communications & Media, Investment Banking, and more.

Pharmaceutical impurity & toxicology consulting firm. Expert PhD team specializing in mutagenic impurities, nitrosamines, OELs, E&L, and excipients. 100+ pharma and biotech clients worldwide.

NurExone is a biotechnology company develops exosome-loaded nanodrugs to treat central nervous system injuries including spinal cord, in a $5B+ market, with strong preclinical results and leadership.

Omnix Medical is redefining the anti-infective landscape with a new class of resistance-breaking therapeutic peptides engineered for first-line use in the most sever bacterial infections.

OrthoTreat develops ModulX®, a first-in-class dual-drug therapy orchestrating natural bone healing across multiple pathways, enabling faster, more reliable, and higher-quality bone regeneration.

Pharmedica is turning orally dissolving films into a programmable therapeutic platform, offering breakthrough architectural designs for sustained controlled release drug delivery systems.

Pitango is Israel’s largest and longest standing venture capital fund. We have raised 13 funds to date that amount to $3+ billion in assets, and invested in over 300 companies.

ProBio is a global CDMO leader in enabling biotech and pharmaceutical companies to advance the development and manufacturing of next-generation biologics and advanced therapies.

Remedy Cell is a clinical stage biopharmaceutical company focused on the discovery and development of cell-derived, cell-free, breakthrough secretome therapies for fibrotic diseases.

We are an Israeli IP firm focused on building medtech patent portfolios and performing patentability and freedom-to-operate analyses, due diligence, litigation, and IP counseling.

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. Learn more about how our expert team members can help accelerate your succes

Vivox is a leading Israeli In-Vivo pre-clinical CRO. We offer expert preclinical services, incl. in-house histology & in-vitro support, for pharmaceutical companies to advance their research!